Data showcased at SABCS and ASH reflect progress and growth of Jazz’s research and development in oncology and demonstrate ongoing efforts to redefine what is possible for cancer treatment DUBLIN, Dec. 3, 2024 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.